Junfeng Shi

RBM38 in cancer: role and mechanism

Dingxiao Zhang, Zhiqiang Dong, C. Zou, 2020, Cellular and Molecular Life Sciences.

Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics.

Jin Hai Zheng, Jianchuang Wang, Yanxia Guo, 2021, Acta biomaterialia.

RBM38 in cancer: role and mechanism

Dingxiao Zhang, Zhiqiang Dong, C. Zou, 2020, Cellular and Molecular Life Sciences.

Stabilization of RRBP1 mRNA via an m6A-dependent manner in prostate cancer constitutes a therapeutic vulnerability amenable to small-peptide inhibition of METTL3

C. Zou, Junfeng Shi, Qinju He, 2023, bioRxiv.

A Stapled Peptide Inhibitor Targeting the Binding Interface of N6-Adenosine-Methyltransferase Subunits METTL3 and METTL14 for Cancer Therapy.

Yang Mei, Junfeng Shi, Weiyu Chen, 2024, Angewandte Chemie.